Guizhou Bailing Group Pharmaceutical Co., Ltd. (SHE:002424)

China flag China · Delayed Price · Currency is CNY
5.01
-0.07 (-1.38%)
Apr 30, 2026, 9:55 AM CST
24.94%
Market Cap 6.93B
Revenue (ttm) 2.93B
Net Income (ttm) -100.35M
Shares Out 1.37B
EPS (ttm) -0.07
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 6,354,000
Average Volume 10,775,696
Open 4.97
Previous Close 5.08
Day's Range 4.96 - 5.08
52-Week Range 3.88 - 6.94
Beta 0.43
RSI 53.83
Earnings Date Apr 28, 2026

About SHE:002424

Guizhou Bailing Group Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells medicines in China. It operates through four segments: Industrial, Commerce, Medical institutions, and Others The company offers medicines in various forms, including tablets, capsules, granules, syrups, powders, pills, dews, pastes, sprays, and oral liquids, as well as wines and honey. Its products are used for cardiovascular, cough, cold, gynecological, and pediatric areas. The company was incorporated in 1999 and is headq... [Read more]

Sector Healthcare
Founded 1999
Employees 6,586
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002424
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.